🔎 Trials Near Me

Home › Acute Lymphoblastic Leukemia › NCT07884474

Feasibility and Acceptability of Remote Saliva Collection

RecruitingObservational studyHealthy volunteers welcome

Who can join

Ages 8 to 18 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

SURVIVORS

* The survivor is a childhood survivor of Acute Lymphocytic Leukemia (ALL).
* The survivor was treated on one of the following St. Jude Total Therapy Studies:

  1. TOTAL Therapy study XVI for Newly Diagnosed Patients with ALL (TOTXVI) OR
  2. Total Therapy for Children with Acute Lymphoblastic Leukemia and Lymphoma (TOT17)
* The survivor is cancer-free.
* The survivor is at least 5 years out from the ALL diagnosis.
* The survivor is at least 2 years out from completion of treatment.
* The survivor did not receive cranial therapy as part of ALL therapy.
* The survivor is aged ≥8 to 18 years old at the time of enrollment.
* The survivor has completed their After Completion of Therapy (ACT) clinic consultation.
* The survivor is able to speak and read English.
* The survivor has internet access.

SIBLINGS

* The sibling has a brother or sister who is an ALL survivor participating in this study.
* The sibling is aged ≥8 to18 years old at the time of enrollment.
* The sibling is able to speak and read English.
* The sibling has internet access.

CAREGIVERS

* The caregiver provides primary care or support to an ALL survivor that is in this study.
* The caregiver resides in the home full-time with enrolled survivor and sibling.
* The caregiver is able to speak and read English.
* The caregiver has internet access.
* The caregiver is willing and able to assist with at home biospecimen collection.

Exclusion Criteria:

SURVIVORS and SIBLINGS

* Survivor and/or sibling has a diagnosis of Down's Syndrome.
* Survivor and/or sibling has a diagnosis of autism spectrum disorder.
* Survivor and/or sibling has a diagnosis of another pervasive developmental disorder not listed above.
* Survivor and/or sibling has a history of prolonged treatment with steroid medications or systemic glucocorticoids for reasons other than ALL.
* Survivor and/or sibling resides outside of the United States.
* Inability or unwillingness of survivor and/or sibling and/or legal guardian/representative to give written informed consent.

CAREGIVERS Note: There are no exclusion criteria for caregivers.

About the study

The purpose of this study is to evaluate the practicality and acceptability of collecting biological samples and health information from childhood survivors of acute lymphoblastic leukemia (ALL) and their siblings. Participants will provide saliva, blood, hair, and fingernail samples, complete questionnaires, and participate in sleep monitoring. The information collected will help researchers understand how cancer treatment and neighborhood conditions may affect stress hormones, inflammation, and long-term health.

Primary Objective

\- To evaluate the feasibility of collecting multiple biological specimens, surveys, and sleep assessment among child and adolescent survivors of ALL and their siblings.

What is being tested

Sponsor: St. Jude Children's Research Hospital · Participants: 100 · Started: 2026-12

Contact the study team

Official record on ClinicalTrials.gov — NCT07884474

Locations in the U.S.

TennesseeSt. Jude Children's Research Hospital, Memphis

Conditions

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.